News
Makers of weight-loss drugs are expected to rake in more than $150 billion in revenue by the early 2030s, thanks to the ...
1don MSN
Half-off Ozempic? US patients paying in cash can now buy the popular weight-loss drug for less
The drug is available as a weight-loss medication under the brand name Wegovy and will now also be sold directly to diabetes ...
Novo Nordisk’s wildly popular GLP-1 drug Wegovy has been approved for use against a serious form of liver disease.
Novo Nordisk released the results from its late-stage trial of CagriSema on Monday. It showed that patients on the highest dose of the drug lost 15.7% of their weight.
Patients' vision loss, which is rare according to a new study, is also the subject of multiple lawsuits, including two filed ...
Novo Nordisk A/S said it has implemented a global hiring freeze as the Danish maker of weight-loss drugs seeks to cut costs ...
Novo Nordisk's GLP-1 drugs have been under considerable competitive pressure in the last few months, so the company will be ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback